Multicentre, Prospective, Open, Non-interventional Study to Evaluate the Effect of Ovaleap on the Pregnancy Rate and Clinical Effects as Well as the User-friendliness of the Ovaleap-Pen in the Clinical Routine of the IVF- / ICSI-treatment.
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 14 Jun 2018
At a glance
- Drugs Follitropin alfa (Primary)
- Indications Female infertility
- Focus Therapeutic Use
- Sponsors Teva Pharmaceutical Industries
- 04 Jun 2018 Planned End Date changed from 3 Mar 2018 to 30 Jun 2018.
- 04 Jun 2018 Planned primary completion date changed from 30 Dec 2017 to 30 Jun 2018.
- 23 Aug 2017 Status changed from recruiting to active, no longer recruiting.